Screening of Bioactive Ingredients in Ligusticum Chuanxiong Hort for Protection against Myocardial Ischemia

Cellular Physiology and Biochemistry

Volumn 40, Issue 3-4, 2016, Pages 770-780

  Liu, Xu ^a   Li, Xiuzhong ^a   Ji, Songgang ^a   Cui, Xiaobo ^a   Li, Mingchun ^a  

^a 401 Hospital of PLA   (China)

Author keywords

Ligusticum Chuanxiong Hort; Myocardial ischemia, spectrum effect relationship

Indexed keywords

CNIDILIDE; CREATINE KINASE; DANSHEN DRIPPING PILL; FATTY ACID; FERULIC ACID; HERBACEOUS AGENT; ISOSORBIDE DINITRATE; LACTIC ACID; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTILIDE; TETRAMETHYLPYRAZINE; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; COUMARIC ACID; GAMMA BUTYROLACTONE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE MODEL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY LIGATION; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG MEGADOSE; DRUG SCREENING; FATTY ACID BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTATE BLOOD LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; PILL; PRIORITY JOURNAL; SALVIA MILTIORRHIZA; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DISEASE MODEL; DOG; LIGUSTICUM; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATHOLOGY; RHIZOME; STANDARD;

4-BUTYROLACTONE; ANIMALS; CARDIOTONIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUMARIC ACIDS; DISEASE MODELS, ANIMAL; DOGS; LIGUSTICUM; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLANT EXTRACTS; REFERENCE STANDARDS; RHIZOME;

EID: 85001754629     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000453137     Document Type: Article

References (44)

1. Chinese Pharmacopoeia Committee: Chinese Pharmacopoeia. Chemical Industry Press. Beijing, China, 2010, Part 1, p.38.
2. Hou YZ, Zhao GR, Yuan YJ, Zhu GG, Hiltunen R: Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis. J Ethnopharmacol 2005;100:140-144.
3. Kim EY, Rhyu MR: Synergistic vasorelaxant and antihypertensive effects of Ligusticumwallichii and Angelica gigas. J Ethnopharmacol 2010;130:545-551.
4. Li W, Tang Y, Chen Y, Duan JA: Advances in the chemical analysis and biological activities of chuanxiong. Molecules 2012;17:10614-10651.
5. Tang Y, Zhu M, Yu S, Hua Y, Duan JA, Su S, Zhang X, Lu Y, Ding A: Identification and comparative quantification of bio-active phthalides in essential oils from si-wu-tang, fo-shou-san, radix angelica and rhizoma chuanxiong. Molecules 2010;15:341-351.
6. Zou KM: Study of ferulic acid extraction processes in chuanxiong. Mod Tradit Chin Med 2005;3:59.
7. Yang XD, Wu X, Hu LC, Guo HN: Effect of different solvents on extraction of effective components from Ligusticum chuanxiong. Chin J Chin Mater Med 2012;37:1942-1945.
8. Yi T, Leung KSY, Lu GH, Chan K, Zhang H: Simultaneous qualitative and quantitative analyses of the major constituents in the rhizome of Ligusticum chuanxiong using HPLC-DADMS. Chem Pharm Bull 2006;54:255-259.
9. Sun Y, Wang W: Ultrasonic extraction of ferulic acid from Ligusticum chuanxiong. J Chin Chem Eng 2008;39:653-656.
10. Yang L, Luo XX, Wang SW, Wang JB: The extraction technology for ferulic acid for Angelica Sinensis (Oliv.) Diels and Ligusticum chuanxiong Hort. by orthogonal design. J Yunnan Coll Tradit Chin Med 2007;30:14-16.
11. Zhan JY, Zheng KY, Zhu KY, Bi CW, Zhang WL, Du CY, Fu Q, Dong TT, Choi RC, Tsim KW, Lau DT: Chemical and biological assessment of Angelicae Sinensis Radix after processing with wine: An orthogonal array design to reveal the optimized conditions. J Agric Food Chem 2011;59:6091-6098.
12. Wang Q, Wu YK: Recent situation of Chinese medicine processing. J Liaoning Univ TCM 2012;14:227-228.
13. Xie ZD, Yi DY, Fang YQ, Guo JS: Studies on traditional pharmaceutical processing for chuanxiong rhizome in medical history and modern research. Chin J Exp Tradit Med Formulae 2012;18:290-293.
14. Xia Q, Wen HL, Li TG, He JE: Determination of free ferulic acid and total ferulic acid in different processed products of Rhizoma chuanxiong by HPLC. J Guangzhou Univ Tradit Chin Med 2009;26:384-387.
15. Zhao Z, Liang Z, Chan K, Lu G, Lee EL, Chen H, Li L: A unique issue in the standardization of Chinese materiamedica: processing. Plant Med 2010;76:1975-1986.
16. The State Pharmacopoeia Commission of P. R. China: Pharmacopoeia of the People's Republic of China Vol. 1. Beijing: Chemical Industry Press, 2010, p. 38.
17. Hu SL: The authentic and superior medicinal herbals in China. Harbin, China, Heilongjiang Science and Technology Publishing House, 1989. p. 461-463.
18. Wang YH, Liang S, Xu DS, Lin X, He CY, Feng Y, Hong YL: Effect and mechanism of senkyunolide I as an antimigraine compound from Ligusticum chuanxiong. J PharmaPharmacol 2011;63:261-266.
19. Li SL, Chan SSK, Lin G, Ling L, Yan R, Chung HS, Tam YK: Simultaneous analysis of seventeen chemical ingredients of Ligusticum chuanxiong by on-line high performance liquid chromatography-diode array detector-mass spectrometry. Planta Med 2003;69:445-451.
20. Ran X, Ma L, Peng C, Zhang H, Qin LP: Ligusticum chuanxiong Hort.: A review of chemistry and pharmacology. Pharm Biol 2011;49:1180-1189.
21. Jin YQ, Hong YL, Li JR, Li X, Wang XX, Lu GH: Advancements in the chemical constituents and pharmacological effects of Chuanxiong. Pharma Clin Chin Materia Medica 2013;4:44-48.
22. Xu X, Ye T, Shuo Y, Yao L, Guang T: Anti-cancer effects of Ligusticum chuanxiong Hort. alcohol extracts on HS766T cell. Afr J Tradit Complement Alter Med 2013;10:542-546.
23. Li CM, Guo YQ, Dong XL, Li H, Wang B, Wu JH, Wong MS, Chan SW: Ethanolic extract of rhizome of Ligusticum chuanxiong Hort. enhances endothelium-dependent vascular reactivity in ovariectomized rats fed with high-fat diet. Food Funct 2014;5:2475-2485.
24. Yue XF, Zhang YN, Zhang ZQ, Tian ZJ, Yang JX, Li FR: Study on the interactions between Ligusticum chuanxiong extract and cardiac muscle membrane receptors by CMSP chromatography. Chin J Chin Materia Medica 2005;30:129-133.
25. Li D, Liu M, Tao TQ, Song DD, Liu XH, Shi DZ: Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/ reperfusion. Cell Physiol Biochem 2014;34:1413-1426.
26. Lu Z, Zhang Y, Zhuang P, Zhang J, Zhou H, Zhang M, Yang X, Wang J, Liu D, Tong Y: Protective effect of Suxiao jiuxin pill, a traditional Chinese medicine, against acute myocardial ischemia in dogs. BMC Complement Altern Med 2015; 15:373.
27. Qian W, Xiong X, Fang Z, Lu H, Wang Z: Protective effect of tetramethylpyrazine on myocardial ischemiareperfusion injury. Evid Based Complement Alternat Med DOI:10.1155/2014/107501.
28. Erqun S, Xu L: Rapid fingerprint analysis of Ligusticum Chuanxiong by UFLC-DAD. J Chromatogr Sci 2013;51:331-334.
29. Yi T, Kelvin Leung SY, Lu GH, Zhang H, Kelvin C: Identification and comparative determination of sekyunolide A in traditional Chinese medicine plants Ligusticum chuanxiong and Angelica sinensis by HPLC with DAD and ESI-MS. Chem Pharm Bull 2005;53:1480-1483.
30. Li SL, Yan R, Tam YK, Lin G: Post-harvest alteration of the main chemical ingredients in Ligusticum chuanxiong Hort. (Rhizoma Chuanxiong). Chem Pharm Bull 2007;55:140-144.
31. Kaplan HR, Giardino EC: Coronary ligation arrhythmias and antiarrhythmic drugs in the 'Harris' and 'reperfusion' dog models. Fed Proc 1977;36.
32. Li SL, Lin G, Tam YK: Time-course accumulation of main bioactive components in the rhizome of Ligusticum chuanxiong. Planta Med 2006;72:278-280.
33. Li W, Tang Y, Chen Y, Duan JA: Advances in the chemical analysis and biological activities of chuanxiong. Molecules 2012;17:10614-10651.
34. Or CT, Yang LH, Law HY, Li CB, Lau SY: Isolation and identication of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia. Neuropharmacology 2011;60:823-831.
35. Huang J, Lu XQ, Lu J, Li GY, Wang HY, Li LH, Lin RC, Wang JH: Two new phthalides with BuChE inhibitory activity from Ligusticumchuanxiong. J Asian Nat Prod Res 2013;15:1237-1242.
36. Chen X, Kong L, Su X, Fu H, Ni J, Zhao R, Zou H: Separation and identification of compounds in Rhizoma chuanxiong by comprehensive two-dimensional liquid chromatography coupled to mass spectrometry. J Chromatogr A 2004;1040:169-178.
37. Li HX, Ding MY, Lv K, Yu JY: Determination of the active ingredients in Chuanxiong by HPLC, HPLC-MS, and EI-MS. J Liquid Chromatog Related Technol 2001;24:2017-2031.
38. Ji SG, Chai YF, Wu YT, Yin XP, Liang DS, Xu ZMng X, Li X: Determination of ferulic acid in Angelica sinensis and Chuanxiong by capillary zone electrophoresis. Biomed Chromatogr 1999;13:333-334.
39. Yi T, Chen Q, He X, So S, Lo Y, Fan L, Xu J, Tang Y, Zhang J, Zhao Z, Chen H: Chemical quantification and antioxidant assay of four active components in Ficushirta root using UPLC-PAD-MS fingerprinting combined with cluster analysis. Chem Cent J 2013;7:115.
40. Qiao CF, Han QB, Song JZ, Mo SF, Kong LD, Kung HF, Xu HX: Chemical fingerprint and quantitative analysis of fructus psoraleae by high-performance liquid chromatography. J Sep Sci 2007;30:813-818.
41. Qin XM, Dai YT, Zhang LZ, Guo XQ, Shao HX: Discrimination of three medicinal materials from the Citrus genus by HPLC fingerprint coupled with two complementary software. Phytochem Anal 2009;20:307-313.
42. Ding XP, Zhang CL, Qi J, Sun LQ, Qin MJ, Yu BY: The Spectrum-Effect integrated fingerprint of Polygonumcuspidatum based on HPLC-diode array detection-flow injection-chemiluminescence. Chin J Nat Med Sept 2013;11:546-552.
43. Yi T, Chen HB, Zhao ZZ, Yu ZL, Jiang ZH: Comparison of the chemical profiles and anti-platelet aggregation effects of two "Dragon's Blood" drugs used in traditional Chinese medicine. J Ethnopharmacol 2011;133:796-802.
44. People's Republic of China Ministry of Health, Bureau of Pharmaceutical Affairs: Processing standards of the People's Republic of China. Beijing, People's Health Press, 1988, p.14.